THE ASSOCIATION BETWEEN EPSTEIN-BARR-VIRUS AND CHINESE HODGKINS-DISEASE

被引:54
作者
ZHOU, XG
HAMILTONDUTOIT, SJ
YAN, QH
PALLESEN, G
机构
[1] AARHUS UNIV HOSP,IMMUNOPATHOL LAB,FINSENSGARE 12,DK-8000 AARHUS,DENMARK
[2] BEIJING HOSP,DEPT PATHOL,BEIJING,PEOPLES R CHINA
[3] BEIJING RAILWAY GEN HOSP,DEPT PATHOL,BEIJING,PEOPLES R CHINA
关键词
D O I
10.1002/ijc.2910550303
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epstein-Barr virus (EBV) can be detected in Hodgkin and Reed-Sternberg (HRS) cells in about one-half of cases of Hodgkin's disease (HD) in Western countries. To determine whether EBV is also associated with HD in a developing country such as China, we studied paraffin sections from 28 Chinese cases of HD for expression of latent membrane protein-1 (LMP-1) and EBV-encoded small RNA (EBER-1), using immunohistology and RNA/RNA in situ hybridization respectively. The cases were selected from a large series of Chinese lymphomas following histological and immunophenotypical revision. EBV gene expression was found in HRS cells in 17/28 cases, and was related to histological sub-type, being present in 10/11 of mixed cellularity, 6/14 nodular sclerosis, 0/1 lymphocytic predominance, 0/1 lymphocytic depletion, and 1/1 unclassified HD. The 2 methods for detecting EBV gene expression gave similar results, except in one case of nodular sclerosis, in which HRS cells were negative for EBER-1, but weakly positive for LMP-1. in 5/12 cases with EBER-negative HRS cells, rare small or medium-sized lymphocytes expressed EBER-1 but not LMP-1. These results suggest that (i) Chinese HD is frequently associated with EBV; (ii) the proportional frequency and sub-type distribution of EBV-positive HD are similar in China and in the West; (iii) both LMP-1 immunohistology and EBER in situ hybridization reliably detect EBV in HRS cells in routine biopsies, but the former is simpler and less resource-consuming to perform. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 54 条
[1]  
ALBUJAR PF, 1973, CANCER, V31, P1520, DOI 10.1002/1097-0142(197306)31:6<1520::AID-CNCR2820310632>3.0.CO
[2]  
2-K
[3]   EPSTEIN-BARR-VIRUS AND CHILDHOOD HODGKINS-DISEASE IN HONDURAS AND THE UNITED-STATES [J].
AMBINDER, RF ;
BROWNING, PJ ;
LORENZANA, I ;
LEVENTHAL, BG ;
COSENZA, H ;
MANN, RB ;
MACMAHON, EME ;
MEDINA, R ;
CARDONA, V ;
GRUFFERMAN, S ;
OLSHAN, A ;
LEVIN, A ;
PETERSEN, EA ;
BLATTNER, W ;
LEVINE, PH .
BLOOD, 1993, 81 (02) :462-467
[4]  
ANAGNOSTOPOULOS I, 1989, BLOOD, V74, P810
[5]  
ARMSTRONG AA, 1992, LEUKEMIA, V6, P869
[6]   FREQUENT EXPRESSION OF EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-1 IN TUMOR-CELLS OF HODGKINS-DISEASE IN HIV-POSITIVE PATIENTS [J].
AUDOUIN, J ;
DIEBOLD, J ;
PALLESEN, G .
JOURNAL OF PATHOLOGY, 1992, 167 (04) :381-384
[7]   IS THE EPSTEIN-BARR VIRUS INVOLVED IN HODGKINS-DISEASE [J].
BOIOCCHI, M ;
CARBONE, A ;
DE RE, V ;
DOLCETTI, R .
TUMORI, 1989, 75 (04) :345-350
[8]   PERSISTENCE OF EPSTEIN-BARR-VIRUS IN REED-STERNBERG CELLS THROUGHOUT THE COURSE OF HODGKINS-DISEASE [J].
COATES, PJ ;
SLAVIN, G ;
DARDENNE, AJ .
JOURNAL OF PATHOLOGY, 1991, 164 (04) :291-297
[9]   EPIDEMIOLOGIC PATTERNS OF HODGKINS DISEASE [J].
CORREA, P ;
OCONOR, GT .
INTERNATIONAL JOURNAL OF CANCER, 1971, 8 (02) :192-+
[10]   EPSTEIN-BARR-VIRUS AND HODGKINS-DISEASE - TRANSCRIPTIONAL ANALYSIS OF VIRUS LATENCY IN THE MALIGNANT-CELLS [J].
DEACON, EM ;
PALLESEN, G ;
NIEDOBITEK, G ;
CROCKER, J ;
BROOKS, L ;
RICKINSON, AB ;
YOUNG, LS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :339-349